A61L27/48

SURGICALLY-FRIENDLY TISSUE PAPERS FROM ORGAN-SPECIFIC DECELLULARIZED EXTRACELLULAR MATRICES
20210275724 · 2021-09-09 ·

Provided herein are inks including decellularized extracellular matrix (dECM) particles and scaffolds made from the inks. Also provided are methods of making the scaffolds and applications for the scaffolds. In an embodiment, a porous scaffold comprises dECM particles and an elastomer, wherein the scaffold is planar having a thickness of about 100 μm or greater, the scaffold comprises irregularly shaped pores having a random orientation and distribution throughout the scaffold, and the scaffold is free of crosslinking between the molecular components of the scaffold.

SURGICALLY-FRIENDLY TISSUE PAPERS FROM ORGAN-SPECIFIC DECELLULARIZED EXTRACELLULAR MATRICES
20210275724 · 2021-09-09 ·

Provided herein are inks including decellularized extracellular matrix (dECM) particles and scaffolds made from the inks. Also provided are methods of making the scaffolds and applications for the scaffolds. In an embodiment, a porous scaffold comprises dECM particles and an elastomer, wherein the scaffold is planar having a thickness of about 100 μm or greater, the scaffold comprises irregularly shaped pores having a random orientation and distribution throughout the scaffold, and the scaffold is free of crosslinking between the molecular components of the scaffold.

Formula for synthesizing bone replacement material, and manufacturing method and application method thereof

A bone material composite granule, a manufacturing method and usage method thereof, and a bone cement constructed using the composite granule. The bone material composite granule comprises a co-polymer of a hydroxyethyl methacrylate (HEMA) and methyl methacrylate (MMA) and a calcium phosphate coated on the surface of the co-polymer. A synthesized bone replacement material has improved biocompatibility, bone conduction, and rheological characteristics, and enhanced mechanics and mechanical performance. The bone material can be used in the fields of osteonecrosis, osteoporosis, osteoarthritis, vertebroplasty, bone fracture, bone cyst, alveolar atrophy, subchondral bone defect, subchondral bone cyst, maxillofacial surgery, plastic surgery, minimally invasive procedure, and the like.

Formula for synthesizing bone replacement material, and manufacturing method and application method thereof

A bone material composite granule, a manufacturing method and usage method thereof, and a bone cement constructed using the composite granule. The bone material composite granule comprises a co-polymer of a hydroxyethyl methacrylate (HEMA) and methyl methacrylate (MMA) and a calcium phosphate coated on the surface of the co-polymer. A synthesized bone replacement material has improved biocompatibility, bone conduction, and rheological characteristics, and enhanced mechanics and mechanical performance. The bone material can be used in the fields of osteonecrosis, osteoporosis, osteoarthritis, vertebroplasty, bone fracture, bone cyst, alveolar atrophy, subchondral bone defect, subchondral bone cyst, maxillofacial surgery, plastic surgery, minimally invasive procedure, and the like.

POROUS BODY AND MATERIAL FOR MEDICAL USE
20210299333 · 2021-09-30 ·

There is provided a porous body which has a first surface and a second surface opposite to each other, and which comprises a first polymer material and a second polymer material, in which a Young's modulus of the first polymer material is lower than a Young's modulus of the second polymer material, an in vivo disappearance rate of the first polymer material is higher than an in vivo disappearance rate of the second polymer material, and a composition in a first region of the porous body and a composition in a second region of the porous body are different from each other.

Composition for dermal injection

The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.

Composition for dermal injection

The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.

TEXTILE PRODUCTS HAVING SELECTIVELY APPLIED SEALANT OR COATING WITH VISUAL INDICATOR AND METHOD OF DETECTING THE SAME

A method of detecting the presence or absence of a sealant applied to a textile graft includes the steps of: providing a textile graft having a first surface and an opposed second surface; providing a water soluble masking agent; applying the water soluble masking agent to at least a portion of the first surface of the textile graft; providing a sealant solution; providing a visual indicator; applying the water insoluble sealing agent and the visual indicator to the second surface of the textile graft; and removing the water soluble masking agent after the step of applying sealing solution. The second surface has visual indication of the visual indicator and the first surface is substantially free of visual indication of the visual indicator. An implantable textile graft includes the selectively applied visual indicator.

TEXTILE PRODUCTS HAVING SELECTIVELY APPLIED SEALANT OR COATING WITH VISUAL INDICATOR AND METHOD OF DETECTING THE SAME

A method of detecting the presence or absence of a sealant applied to a textile graft includes the steps of: providing a textile graft having a first surface and an opposed second surface; providing a water soluble masking agent; applying the water soluble masking agent to at least a portion of the first surface of the textile graft; providing a sealant solution; providing a visual indicator; applying the water insoluble sealing agent and the visual indicator to the second surface of the textile graft; and removing the water soluble masking agent after the step of applying sealing solution. The second surface has visual indication of the visual indicator and the first surface is substantially free of visual indication of the visual indicator. An implantable textile graft includes the selectively applied visual indicator.

Composition for dermal injection

The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.